Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with an interchangeable designationPotential benefit to the ...
JAMES RODRIGUEZ’s club have shut down rumours that the Colombia midfielder has a potentially fatal muscle-wasting condition.
Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from stealth mode and collaboration with ...
Colombian international midfielder James Rodriguez’s club has vehemently denied widespread social media rumors that the ...
The 34-year-old was in hospital for three days after suffering with “severe dehydration” following his Colombia’s friendly with France.
The Lancet obesity framework aims to improve risk assessment but risks delaying treatment and deepening health inequities, according to recent evaluations.
A study finds metabolomic signatures linked to healthy diets may reduce knee osteoarthritis risk, with BMI mediating much of the association.
Demand for hip replacements is rising. Around 100,000 of the procedures are performed each year in the UK, and by 2060 this ...
Patients with dermatomyositis in the US experience substantial variability in treatment, high glucocorticoid exposure, and significant healthcare utilization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results